Kancera AB (publ) (KAN.ST)

SEK 1.22

(9.09%)

Eps Summary of Kancera AB (publ)

  • Kancera AB (publ)'s latest annual eps in 2023 was -0.80 SEK , up 9.09% from previous year.
  • Kancera AB (publ)'s latest quarterly eps in 2024 Q1 was -0.13 SEK , up 40.91% from previous quarter.
  • Kancera AB (publ) reported an annual eps of -0.88 SEK in 2022, down -29.41% from previous year.
  • Kancera AB (publ) reported an annual eps of -0.68 SEK in 2021, up 37.04% from previous year.
  • Kancera AB (publ) reported a quarterly eps of -0.13 SEK for 2024 Q1, up 40.91% from previous quarter.
  • Kancera AB (publ) reported a quarterly eps of -0.13 SEK for 2023 Q3, up 40.91% from previous quarter.

Annual Eps Chart of Kancera AB (publ) (2023 - 2010)

Historical Annual Eps of Kancera AB (publ) (2023 - 2010)

Year Eps Eps Growth
2023 -0.80 SEK 9.09%
2022 -0.88 SEK -29.41%
2021 -0.68 SEK 37.04%
2020 -1.08 SEK 23.4%
2019 -1.41 SEK 32.86%
2018 -2.10 SEK 32.26%
2017 -3.10 SEK -124.64%
2016 -1.38 SEK -2.99%
2015 -1.34 SEK -8.94%
2014 -1.23 SEK 14.58%
2013 -1.44 SEK 84.4%
2012 -9.23 SEK -46.04%
2011 -6.32 SEK -134.94%
2010 -2.69 SEK 0.0%

Peer Eps Comparison of Kancera AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -45.455%
Ziccum AB (publ) -1.54 SEK 48.052%
Modus Therapeutics Holding AB (publ) -1.01 SEK 20.792%
BioArctic AB (publ) 2.60 SEK 130.769%
Sprint Bioscience AB (publ) -0.01 SEK -12598.413%
Mendus AB (publ) -4.40 SEK 81.818%
Genovis AB (publ.) 0.94 SEK 185.106%
Intervacc AB (publ) -1.69 SEK 52.663%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -263.636%
Active Biotech AB (publ) -0.17 SEK -370.588%
Magle Chemoswed Holding AB (publ) 1.13 SEK 170.796%
Bio-Works Technologies AB (publ) -1.57 SEK 49.045%
Aptahem AB (publ) -0.05 SEK -1556.315%
Vicore Pharma Holding AB (publ) -3.22 SEK 75.155%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 91.96%
Fluicell AB (publ) -0.24 SEK -233.333%
Saniona AB (publ) -1.29 SEK 37.984%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -321.053%
Biovica International AB (publ) -2.14 SEK 62.617%
Spago Nanomedical AB (publ) -0.43 SEK -86.047%
AcouSort AB (publ) -1.29 SEK 37.984%
Xintela AB (publ) -0.13 SEK -515.385%
Abliva AB (publ) -0.09 SEK -784.956%
Egetis Therapeutics AB (publ) -1.27 SEK 37.008%
Karolinska Development AB (publ) 0.02 SEK 4100.0%
OncoZenge AB (publ) -1.36 SEK 41.176%
Amniotics AB (publ) -0.01 SEK -7172.727%
2cureX AB (publ) -1.85 SEK 56.757%
CombiGene AB (publ) -1.80 SEK 55.556%
Asarina Pharma AB (publ) -0.57 SEK -40.351%
Calliditas Therapeutics AB (publ) -8.69 SEK 90.794%
Camurus AB (publ) 7.78 SEK 110.283%
Corline Biomedical AB -0.08 SEK -850.119%
IRLAB Therapeutics AB (publ) -3.43 SEK 76.676%
Isofol Medical AB (publ) -0.23 SEK -247.826%
I-Tech AB 1.70 SEK 147.059%
Hansa Biopharma AB (publ) -15.83 SEK 94.946%
Cyxone AB (publ) -0.22 SEK -263.636%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 59.596%
Biosergen AB -0.60 SEK -33.333%
Cantargia AB (publ) -1.65 SEK 51.515%
NextCell Pharma AB -1.03 SEK 22.33%
Xspray Pharma AB (publ) -6.76 SEK 88.166%
Elicera Therapeutics AB (publ) -0.83 SEK 3.614%
Nanologica AB (publ) -2.05 SEK 60.976%
SynAct Pharma AB -6.64 SEK 87.952%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -207.692%
Stayble Therapeutics AB (publ) -0.92 SEK 13.043%
LIDDS AB (publ) -0.63 SEK -26.984%
Lipum AB (publ) -4.45 SEK 82.022%
BioInvent International AB (publ) -5.02 SEK 84.064%
Alzinova AB (publ) -0.41 SEK -95.122%
Oncopeptides AB (publ) -1.96 SEK 59.184%
Pila Pharma AB (publ) -0.47 SEK -70.213%
Guard Therapeutics International AB (publ) -11.26 SEK 92.895%
Scandinavian ChemoTech AB (publ) -1.13 SEK 29.204%
Simris Alg AB (publ) -0.16 SEK -400.0%
Diamyd Medical AB (publ) -1.60 SEK 50.0%
Xbrane Biopharma AB (publ) -1.27 SEK 37.008%
Ascelia Pharma AB (publ) -3.24 SEK 75.309%
Diagonal Bio AB (publ) -0.32 SEK -150.0%